Skip to main content
Back
Watch Compare

Welsis Corp.

Data quality: 100%
WLSS
OTC Services Health Services
$4.60
$0.00 (0.00%)
Mkt Cap: 12.66 M
Price
$4.60
Mkt Cap
12.66 M
Day Range
$3.47 — $3.50
52-Week Range
$0.40 — $4.64
Volume
600
Open $3.47
50D / 200D Avg
$3.94
16.64% above
50D / 200D Avg
$3.16
45.36% above

Quick Summary

Key Takeaways

Negative free cash flow of -51,183.0

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.01
Interest Coverage-3.10

Valuation

PE (TTM)
-272.58
Below sector avg (-0.01)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (20 peers)
Metric Stock Sector Median
P/E -272.6 0.0
P/B — 3.1
ROE % — -1.5
Net Margin % — -0.3
Rev Growth 5Y % — 19.1
D/E — 1.0

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -46,454.0
ROE N/A ROA -2819.67%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -51,183.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.01
Interest Coverage -3.10 Asset Turnover 0.00
Working Capital -81,934 Tangible Book Value -160,351
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -272.58 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0.40%
Market Cap 12.66 M Enterprise Value 12.66 M
Per Share
EPS (Diluted TTM) -0.01 Revenue / Share 0.00
FCF / Share -0.02 OCF / Share -0.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 110.18%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 0.0 2,000.0 15,900.0 0.0
Net Income -60,690.0 -24,683.0 -41,068.0 -42,785.0
EPS (Diluted) -0.02 0.00 0.00 0.00
Gross Profit 0.0 2,000.0 — —
Operating Income -50,573.0 -57,898.0 -41,068.0 -42,785.0
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A — — — —
Interest Expense 10,117.0 6,452.0 — —
Income Tax — — 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 2,169.0 0.0 33,167.0 50,036.0
Total Liabilities 152,500.0 89,641.0 151,140.0 126,941.0
Shareholders' Equity -150,331.0 -89,641.0 -117,973.0 -76,905.0
Total Debt — — — —
Cash & Equivalents — — — —
Current Assets 2,169.0 0.0 9,834.0 18,703.0
Current Liabilities 84,608.0 71,696.0 111,140.0 86,941.0